Recorded Webinar with Dr. Phyllis I. Warkentin: A First Look at the NetCord-FACT 6th Edition Cord Blood Standards
Share the Science
Watch the recorded webinar to hear Dr. Phyllis I. Warkentin, Chief Medical Officer of the Foundation for the Accreditation of Cellular Therapy (FACT), discuss the 6th edition NetCord-FACT Standards that will be published in July 2016.
The 6th edition NetCord-FACT Standards will be published in July 2016, and this exciting webinar provides an overview of the newly updated requirements. Standards are reviewed and updated every three years based on scientific advances, recommendations from cord blood banking experts, and common deficiencies. Dr. Warkentin discusses some of the significant changes, describes why those changes were made, and provides recommendations for complying with the new standards.
You Will Learn:
- The significant changes made in the 6th edition NetCord-FACT Cord Blood Standards
- Why these changes were made to the standards
- Methods for transitioning to the new standards
Phyllis I. Warkentin, M.D., discusses the 6th edition NetCord-FACT Standards.
Phyllis I. Warkentin, M.D., is the Chief Medical Officer of the Foundation for the Accreditation of Cellular Therapy (FACT), Professor of Pathology/Microbiology and Pediatrics at the University of Nebraska Medical Center College of Medicine, and medical director of the Biologics Production Facility at UNMC. Dr. Warkentin is board certified in pediatric hematology/oncology and transfusion medicine. As a founding member of the FACT Board of Directors, Dr. Warkentin established the standards-setting and accrediting arm of FACT’s parent organizations: The American Society for Blood and Marrow Transplantation (ASBMT) and the International Society for Cellular Therapy (ISCT). She is a recipient of the ASBMT Public Service Award and serves on international committees for numerous cellular therapy professional societies and organizations.
Mediware and Save the Cord Foundation are proud to bring you this exclusive speaker series to discuss the topics you and your peers are most interested in. Join us as we feature your colleagues to discuss their latest research, opinions on industry news and so much more. We look forward to having you on board for this exciting series!